ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Finalists Named in Global Health Technology Competition to Advance Heart and Brain Health

The competition offers a live forum for health care technology companies to present innovations designed to prevent or treat cardiovascular conditions, including high blood pressure, stroke, heart failure and related conditions.

This year’s five selected finalists will present their solutions in the Health Innovation Pavilion during Scientific Sessions 2025 - the American Heart Association’s flagship global event for the latest research and clinical advancements in cardiovascular science. Finalists include:

  • Brainomix (in Oxford, England): Creating AI-powered software to improve stroke diagnosis and treatment decisions.
  • Cambrian Health (San Francisco): Building an AI-powered platform that ensures clinical best practices are seamlessly executed at the point of care.
  • Lumia (Boston): Delivering wearable solutions for people with orthostatic intolerance and chronic blood flow disorders.
  • Noah Labs (Berlin): Transforming voice into a digital biomarker to enable earlier intervention for cardiometabolic diseases.
  • PolyVascular (Houston, Texas): Developing minimally invasive solutions for children with congenital heart disease, aiming to reduce the need for repeated open-heart surgeries.

Final presentations will be delivered live at the New Orleans Ernest N. Morial Convention Center, Nov. 8–9, from 11:30 a.m. to 1 p.m. CT.

Finalists’ presentations will be evaluated based on:

  • Validity: How well is the working prototype or product functioning in the market with customers?
  • Scientific Rigor: How well does validation research use evidence-based health research?
  • Impact: To what extent does the product improve patient outcomes through innovative technology?

A panel of expert volunteer judges will review business and science presentations from each company. Judges include:

  • Eric D. Peterson, M.D., M.P.H., FAHA, professor of medicine in the division of cardiology at UT Southwestern Medical Center
  • Lee Shapiro, J.D., volunteer chairman of the board of the American Heart Association and co-founder and managing partner of 7WireVentures
  • Lisa Suennen, managing partner at American Heart Association Ventures
  • Ken Nelson, partner at the Med Tech Innovators Advantage Fund
  • Craig Beam, president of Beam & Associates
  • Tim Benner, chief strategy officer and chief marketing officer of Masimo
  • Henry Peck, chief business officer of LSI
  • Star Jones, lawyer/TV personality, Divorce Court, and American Heart Association national volunteer
  • Lee H. Schwamm, M.D., FAHA, associate dean of digital strategy and transformation at Yale School of Medicine
  • Joseph C. Wu, M.D., Ph.D., FAHA, volunteer past president (2023-24) of the American Heart Association, professor and director at the Stanford Cardiovascular Institute and co-founder of Greenstone Biosciences
  • Michael V. McConnell, M.D., MSEE, clinical professor of medicine at Stanford University School of Medicine
  • Asif Ali, M.D., clinical associate professor of cardiovascular medicine at the University of Texas Medical School in Houston and director at Cena Research Institute
  • Jessica Golbus, M.D., M.S., FAHA, assistant professor at the University of Michigan
  • Ashoo Tandon, M.D., M.S., FAHA, FAAP, FACC, pediatric cardiologist, director of cardiovascular innovation and associate staff at Cleveland Clinic Children’s
  • Dave Albert, M.D., founder of AliveCor
  • Daniel Cantillon, M.D., chief medical officer of Masimo

The winner will be announced live in New Orleans on Nov. 9 and will receive complimentary membership in the Center for Health Technology & Innovation Innovators’ Network, a consortium connecting entrepreneurs, providers, researchers and payers to advance cardiovascular and brain health innovation. Members collaborate with the Center and each other in different ways, including: building models for clinical outcome studies - which lowers the significant cost of developing those studies independently; helping connect the science to technology; and providing evidence that a digital platform improves health care outcomes - a key concern for providers and payers.

Innovators’ Network members also have the opportunity to access the American Heart Association’s digital evidence-based scientific guidelines and clinical recommendations as they develop digital health care technologies.

“The Center for Health Technology & Innovation aims to advance the rapid, efficient and effective development of health care technology,” said Robert A. Harrington, M.D., FAHA, volunteer past president of the American Heart Association (2019-2020), volunteer chair of the Association’s Health Tech Advisory Group for the Center and the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University. “Joining the Innovators’ Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena.”

To learn more about the Health Tech competition, visit: ahahealthtech.org/aha-health-tech-competition-2025.

The Association receives more than 85% of its revenue from sources other than corporations. These sources include contributions from individuals, foundations and estates, as well as investment earnings and revenue from the sale of our educational materials. Corporations (including pharmaceutical, device manufacturers and other companies) also make donations to the Association. The Association has strict policies to prevent any donations from influencing its science content and policy positions. Overall financial information is available here.

Additional Resources:

About the American Heart Association

The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public’s health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on heart.org, Facebook, X or by calling 1-800-AHA-USA1.

For Media Inquiries: 214-706-1173

Monica Sales: monica.sales@heart.org

For Public Inquiries: 1-800-AHA-USA1 (242-8721)

heart.org and stroke.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.41
+1.37 (0.56%)
AAPL  268.47
-1.30 (-0.48%)
AMD  233.54
-4.16 (-1.75%)
BAC  53.20
-0.09 (-0.17%)
GOOG  279.70
-5.64 (-1.98%)
META  621.71
+2.77 (0.45%)
MSFT  496.82
-0.28 (-0.06%)
NVDA  188.15
+0.07 (0.04%)
ORCL  239.26
-4.54 (-1.86%)
TSLA  429.52
-16.39 (-3.68%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.